Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CleanSpace Holdings Ltd. ( (AU:CSX) ) has provided an announcement.
CleanSpace reported H1 FY26 revenue of $10.1 million, up 10% year on year, with gross margin improving to 75% and cash at bank rising 18% to $9.8 million, indicating sustained growth and strong unit economics. Operating EBITDA remained slightly negative at -$0.3 million but improved 23% versus the prior comparable period as the company balanced disciplined cost control with investment for future expansion.
Europe continued to be the main growth engine with sales up 26% to $6.7 million, driven by strong gains in Western Europe and the Nordics, while APAC and rest of world revenue fell 22% due to prior-year one-offs and slower Australian pipeline development. Management upgraded its FY26 outlook to target about 15% revenue growth, mid-70% gross margins, positive operating EBITDA in the second half and full-year positive cash flow, while committing to reinvest surplus cash to support international growth and market penetration.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.58 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
More about CleanSpace Holdings Ltd.
CleanSpace Holdings Ltd. is an Australian manufacturer of premium respiratory protection solutions serving industrial and healthcare markets. The company focuses on high-margin, powered air respiratory products and is expanding its presence in key geographies, particularly Europe, supported by a maturing distributor network and ongoing product certification efforts in Asia.
Average Trading Volume: 23,580
Technical Sentiment Signal: Sell
Current Market Cap: A$46.14M
Learn more about CSX stock on TipRanks’ Stock Analysis page.